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Reply to the Editor: 
I appreciate the research into the area of bronchial 
blockade done by Drs. Fontana and Nazari. When I first 
began to design the Univent tube (Fuji Systems Corpora- 
tion, Tokyo, Japan), my objectives were to create an 
endobronchial tube that was easy to place by clinicians not 
used to such procedures, a device that could ventilate the 
patient's lungs adequately without adding to gas flow 
resistance, and a device that could easily support he use 
of a fiberoptic bronchoscope. I believe the Univent tube 
has achieved these goals. 
My original etter to the Editor 1 explained to surgeons 
the various ways the Univent tube could make lee (in the 
operating room) easier for rhein. 
The types of cases Drs. Fontana and Nazari describe 
are not easy, especially when using a new and perhaps 
unfamiliar device. For these reasons I did not indicate the 
use of Univent tubes for tracheal, carinal, or main-stem 
bronchial resections. I have anecdotal reports of these 
cases being performed with the bronchial umen of the 
Univent tube being used as a "jet stylet," ventilating the 
nonsurgical lung by means of high-frequency jet ventila- 
tion with the blocker cuff deflated to allow for escaping 
gases. These cases were performed by anesthesiologists 
and surgeons well versed in the use of the Univent tube 
and advanced surgical ventilation techniques. 
For the Univent tube to be used properly, as with all 
medical devices, it is wise to start on the easier and more 
routine cases to gain experience. The Univent tube will 
accept standard-sized fiberoptic bronchoscopes for visual- 
ization and placement of the bronchial blocker. If the 
instruction manual is followed, right-sided placement of 
the blocker is safe and simple to perform. 
I designed the Univent tube to simplify the concept of 
the endotracheal tube and balloon occlusion catheter 
technique for lung separation. The tube described by 
Drs. Fontana and Nazari seems to reintroduce the 
difficulties of Fogarty catheters for the surgeon/anes- 
thesiologist. 
Hiroshi Inoue, MD 
First Department of Surgery 
School of Medicine 
Tokai University 
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Aprotinin and vein graft occlusion after coronary 
artery bypass 
To the Editor: 
We were interested to read the article by Havel and 
colleagues (J THORAC CARDIOVASC SURG 1994;107:807- 
10), which concluded that aprotinin significantly reduced 
postoperative bleeding without influencing early vein graft 
patency in a series of 45 patients undergoing coronary 
artery bypass. The number of patients in this study is 
inadequate, however, to make any conclusion regarding 
the effect aprotinin may have on the early patency of 
coronary vein gratis. 
The most appropriate method of statistical analysis of 
data concerning vein graft patency has frequently been 
debated, but it seems clear that comparison of rein graft 
patency rates by distal anastomoses alone is inadequate. 
Many factors may influence early graft occlusion, and 
recent studies that have compared the patency and occlu- 
sion of distal anastomoses within patients have shown that 
these are dependent events. 1 It is therefore important 
when investigating the effect of a single variable on vein 
graft patency that a comparison be made of the proportion 
of patients with at least one occluded graft. This important 
point has been made previously, emphasizing the fact that 
individual gratis within a patient are unlikely to behave 
independently. 2 Taking this into account, we have calcu- 
lated that assuming 25% of patients in the control group 
would have one occluded graft or more (from pooled 
data), 290 patients per treatment group would be required 
for a 50% reduction in the risk of occlusion to be detected, 
specifying an alpha error of 5% (two-sided) and a beta 
error of 10%. This is in keeping with the statistical 
estimates of some of the recently published trials regard- 
ing the effect of antiplatelet agents on vein graft occlu- 
sion.3, 4 
Another article published recently addressing the issue 
of aprotinin and vein graft patency found no difference in 
patency rates between treatment and control groups (as 
assessed by ultrafast computed tornography) but con- 
cluded that despite randomizing 216 patients, the num- 
bers were too small to make firm statistical conclusions. » 
The comparison of occlusion rates in 15 patients per 
treatment group as performed by Havel and associates i
therefore inappropriate. Larger trials will have to be 
performed before we can be convinced of their conclu- 
sion. 
M. J. Underwood, MD a 
G. J. Cooper, MD b 
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The Brook Hospital b 
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